Immune Profiling Core
免疫分析核心
基本信息
- 批准号:9980787
- 负责人:
- 金额:$ 46.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-15 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:Adjuvant TherapyAntibodiesAntigensAutopsyB-LymphocytesBiological AssayBiological Specimen BanksBiopsyBody FluidsCatalogsCell DeathCellsChairpersonClinicalColorCommunicable DiseasesCore FacilityCryopreservationCytomegalovirusEnvironmentFlow CytometryHealth Services ResearchHistologyHumanHuman Herpesvirus 4ImmuneImmunizationImmunoassayImmunocompromised HostImmunohistochemistryImmunologicsImmunologyImmunology procedureIndividualInfrastructureKidney TransplantationKnowledgeLaboratoriesLasersLeadLeadershipLymphocryptovirusMacaca mulattaManagement Information SystemsMemory B-LymphocyteMonitorOperative Surgical ProceduresPeripheral Blood Mononuclear CellPhenotypePlasmaPlasma CellsPositioning AttributePrior TherapyProceduresProteasome InhibitionRegimenRegulationResearchResearch SupportResource SharingRhesusRiskSafetySamplingScientistSerumServicesSimian virus 40SirolimusSpecimenSpecimen HandlingStainsStandardizationStructure of germinal center of lymph nodeSupervisionT-LymphocyteTechnical ExpertiseTestingThymus GlandTissue SampleTissuesTransplantationUniversitiesViralViral AntigensVirus LatencyWorkbasebiobankclinically relevantcytokinedesensitizationdigitalexhaustioninstrumentkidney allograftlaboratory experiencelymph nodesmedical schoolsnonhuman primatepost-transplantpreventprogramsquality assuranceresearch studysecondary lymphoid organsingle cell analysissynergismtesting servicesvirology
项目摘要
ABSTRACT – Immune Profiling Core
The Immune Profiling Core (IPC) will provide comprehensive technical assay support services for the
hypothesis-driven research studies proposed in the two Projects comprising this U19 proposal. The Core
derives its greatest overall strength from the relevant expertise, organization, procedures, and operational
synergy of its components. Anchoring these efforts is the Duke Immune Profiling Core (DIPC), a Duke School
of Medicine Shared Resource that has been in existence since 1988. Largely focused on flow cytometry-based
platforms for human immune profiling, the Core has actively participated in external proficiency testing and
quality assurance programs for over 25 years. Assay testing is performed in a Good Clinical Laboratory
(GCLP)-compliant environment according to highly standardized and validated Standard Operating Procedures
(SOPs). The Core is joined in its efforts by a support team of highly experienced laboratory professionals from
the Kirk and Knechtle research Cores who have recently re-located to Duke from Emory University. These
individuals have extensive expertise in all aspects of transplantation research, both in human and nonhuman
primate (NHP) studies. The key services the IPC will provide to Projects 1 and 2 include: 1) state-of-the-art
specimen processing and biobanking, 2) analytical polychromatic flow cytometry (PFC) phenotyping, and
intracellular cytokine staining (ICCS), 3) virologic testing, and 4) comprehensive histology and
immunohistochemistry support. The IPC is well positioned to provide PFC services to the projects under this
proposal; PFC having been the technical mainstay of the research endeavors of the DIPC. The present core
facility houses a 4-laser BD LSRII, 5-laser BD LSRFortessa, 5-laser BD LSR-X20 and, most recently, a 5-laser
BD LSR-X50. Of these digital instruments, the first 3 are capable of up to 18-24 parameter single cell analyses,
while the X50 is capable of supporting 50-parameter flow cytometry. To provide comprehensive immunologic
support, we have implemented several highly developed components for the IPC. A specimen processing and
biobanking service that began at Emory under Dr. Kirk has been re-established as the Substrate Services and
Research Support Service (SSCRSS) at Duke following his arrival as Chairman of the Department of Surgery.
Through the work of Dr. Kirk's laboratory, we have also established a viral testing facility that will allow the IPC
to monitor three of the most clinically-relevant latent viruses in NHPs: Rhesus Cytomegalovirus (rhCMV),
Rhesus Lymphocryptovirus (rhLCV) (rhesus homology of EBV), and Simian Virus 40 (SV40). The IPC will
provide routine histology and immunohistochemistry assays through our immunohistochemistry service
laboratory, which will allow each project to examine the effects of the experimental manipulations on key host
tissue. Special emphasis will be placed on examining effects on germinal center formation following the various
induction regimens. The juxtaposition of human and NHP expertise represents a particular strength of this IPC
consortium, further facilitating the highly translational aspects of the proposed studies.
抽象-免疫分析核心
免疫分析核心(IPC)将提供全面的技术检测支持服务
这两个构成U19提案的项目中提出的假设驱动的研究。《核心》
从相关的专业知识、组织、程序和运营中获得最大的综合实力
其组成部分的协同效应。支撑这些努力的是杜克免疫档案核心(DIPC),一个杜克学校
自1988年以来一直存在的医学共享资源。主要集中在基于流式细胞术的
作为人类免疫分析平台的一部分,核心积极参与外部能力测试和
超过25年的质量保证计划。化验应在良好的临床实验室中进行
符合(GCLP)的环境,符合高度标准化和经过验证的标准操作程序
(天哪)。一支由来自以下国家的经验丰富的实验室专业人员组成的支持团队加入了Core的工作
柯克和克内克特尔的研究核心最近从埃默里大学调到了杜克大学。这些
个人在人类和非人类移植研究的各个方面都有广泛的专业知识。
灵长类(NHP)研究。IPC将为项目1和项目2提供的主要服务包括:1)最先进的
标本处理和生物库,2)分析多色流式细胞术(PFC)表型,以及
细胞内细胞因子染色(ICCS),3)病毒学检测,4)综合组织学和
免疫组织化学支持。IPC处于有利地位,可以向该计划下的项目提供PFC服务
提案;PFC一直是DIPC研究工作的技术支柱。目前的核心
该设施配备了4激光器BD LSRII、5激光器BD LSRFortessa、5激光器BD LSR-X20,以及最近的5激光器
BD LSR-X50。在这些数字仪器中,前3台能够进行多达18-24个参数的单细胞分析,
而X50能够支持50个参数的流式细胞仪。提供全面的免疫学
为了提供支持,我们为IPC实现了几个高度开发的组件。一次样品加工和
在柯克博士的领导下开始于埃默里的生物库服务已重新建立为底物服务和
在杜克就任外科主任后,他在杜克大学获得了研究支持服务(SSCRSS)。
通过柯克博士实验室的工作,我们还建立了一个病毒测试设施,将允许IPC
为了监测NHP中与临床相关性最强的三种潜伏病毒:恒河猴巨细胞病毒(RhCMV),
恒河猴淋巴病毒(RhLCV)(与EB病毒同源)和猿猴病毒40(SV40)。IPC将
通过我们的免疫组织化学服务提供常规的组织学和免疫组织化学分析
实验室,这将允许每个项目检查实验操作对关键主机的影响
组织。将特别强调检查生发中心形成的影响之后的各种
诱导疗法。人力和NHP专业知识的并列代表了这一IPC的特殊优势
财团,进一步促进拟议研究的高度翻译性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kent J. Weinhold其他文献
Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors.
来自人类免疫缺陷病毒血清阳性供体的 IgG 静脉注射溶液的制备和表征。
- DOI:
10.1182/blood.v77.5.1111.bloodjournal7751111 - 发表时间:
1991 - 期刊:
- 影响因子:20.3
- 作者:
Larry M. Cummins;Kent J. Weinhold;Thomas J. Matthews;A. J. Langlois;C. F. Perno;RICHARD M. Condie;Jean - 通讯作者:
Jean
Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein.
HIV 包膜糖蛋白中和单克隆抗体的特征。
- DOI:
- 发表时间:
1988 - 期刊:
- 影响因子:1.5
- 作者:
Michael A. Skinner;Robert Ting;A. J. Langlois;Kent J. Weinhold;H. K. Lyerly;K. Javaherian;Thomas J. Matthews - 通讯作者:
Thomas J. Matthews
3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase
3-叠氮基-3-脱氧胸苷三磷酸作为纯化人免疫缺陷病毒逆转录酶的抑制剂和底物
- DOI:
10.1128/aac.31.12.1972 - 发表时间:
1987 - 期刊:
- 影响因子:4.9
- 作者:
M. H. S. Clair;Cynthia A. Richards;Thomas Spector;Kent J. Weinhold;Wayne H. Miller;A. J. Langlois;Phillip A. Furman - 通讯作者:
Phillip A. Furman
Measurement of direct and indirect forms of anti-HIV-1 ADCC: implications for other retroviral disease.
抗 HIV-1 ADCC 的直接和间接形式的测量:对其他逆转录病毒疾病的影响。
- DOI:
- 发表时间:
1990 - 期刊:
- 影响因子:0
- 作者:
Kent J. Weinhold;Douglas S. Tyler;H. K. Lyerly - 通讯作者:
H. K. Lyerly
Coupling Hematoma Evacuation with Immune Profiling for Analysis of Neuroinflammation After Primary Intracerebral Hemorrhage: A Pilot Study
- DOI:
10.1016/j.wneu.2022.02.062 - 发表时间:
2022-05-01 - 期刊:
- 影响因子:
- 作者:
Jay B. Lusk;Quintin J. Quinones;Janet S. Staats;Kent J. Weinhold;Peter M. Grossi;Shahid M. Nimjee;Daniel T. Laskowitz;Michael L. James - 通讯作者:
Michael L. James
Kent J. Weinhold的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kent J. Weinhold', 18)}}的其他基金
Biorepository, Pathology, and Immune Monitoring Core
生物样本库、病理学和免疫监测核心
- 批准号:
10248315 - 财政年份:2014
- 资助金额:
$ 46.12万 - 项目类别:
Biorepository, Pathology, and Immune Monitoring Core
生物样本库、病理学和免疫监测核心
- 批准号:
10705239 - 财政年份:2014
- 资助金额:
$ 46.12万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 46.12万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 46.12万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 46.12万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 46.12万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 46.12万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 46.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 46.12万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 46.12万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 46.12万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 46.12万 - 项目类别:
Standard Grant














{{item.name}}会员




